Medicinal Products

Tecentriq

Name Tecentriq
Active Substance atezolizumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Vodič za zdravstvene radnike, verzija 4
Educational materials
for patients / caregivers
Kartica s upozorenjem za bolesnika, verzija 3

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/tecentriq

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o ograničenju indikacije lijeka Tecentriq (atezolizumab) 10.07.2018 Roche Registration GmbH
Back